Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172740 | SCV000051364 | benign | Primary dilated cardiomyopathy | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000038848 | SCV000062526 | likely benign | not specified | 2015-08-21 | criteria provided, single submitter | clinical testing | p.Val107Leu in exon 3 of ANKRD1: This variant is not expected to have clinical s ignificance because it has been identified in 0.8% (81/10346) of African chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs114435632). |
Gene |
RCV001701651 | SCV000235710 | likely benign | not provided | 2020-10-07 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23299917, 20981092, 19608030, 19608032, 27143260, 27896284) |
Invitae | RCV000468471 | SCV000563270 | benign | ANKRD1-related dilated cardiomyopathy | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620745 | SCV000735851 | likely benign | Cardiovascular phenotype | 2018-08-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000038848 | SCV000740550 | benign | not specified | 2016-08-30 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000770307 | SCV000901740 | likely benign | Cardiomyopathy | 2017-02-16 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001701651 | SCV001156623 | likely benign | not provided | 2021-04-13 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000038848 | SCV004038186 | likely benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000038848 | SCV001921750 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001701651 | SCV001931830 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001701651 | SCV001951424 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001701651 | SCV001966606 | likely benign | not provided | no assertion criteria provided | clinical testing |